ASND (Ascendis) Wutah bathi ing taun lumaku
The Ascendis Pharma A/S (ASND) ecosystem is based on the innovative TransCon technology, which ensures high patient loyalty. Measurable YoY EPS growth confirms this trend, where 486.80 shows the level of this metric. Business efficiency relies on certified cold chain supplies for biologics, while scaling potential is embedded in the low production costs of patented long-acting agents.
Rincian metrik keuangan lan pasar Ascendis Pharma A/S (ASND)
- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
- data kapitalisasi buku:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Ascendis Pharma A/S|ASND - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal ascendispharma.com|ASND - Utang perusahaan|Utang-utang marang aset resik Ascendis|ASND - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Ascendis Pharma|Rasio cepet ascendispharma.com
- informasi bathi lan kelipatan valuasi:
ASND - Bathi resik perusahaan|Prakiraan bathi perusahaan Ascendis Pharma A/S|ASND - Pangali P/E|Prakiraan rega marang bathi Ascendis|ASND - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ascendis|ASND - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Ascendis Pharma|ASND - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan ascendispharma.com|ASND - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Ascendis Pharma A/S
Analisis dhasar perusahaan:ASND - Ascendis Pharma AS
The use of AI and TransCon automated platforms accelerates drug synthesis for Ascendis Pharma A/S (ASND), directly impacting profit scalability. By analyzing the history of annual earnings per share changes, an investor assesses net income growth rates relative to the previous year, allowing for the timely detection of cooling demand or declining cost efficiency to avoid the trap of illusory infinite growth.
Pesaing utama
MDGL: Wutah bathi resik saben siji saham kanggo taun lumaku|CORT (Corcept) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Rhythm Corp|Wutah bathi ing taun lumaku AKRO|Wutah bathi saben saham ing taun lumaku MTSR (metsera.com)|Wutah bathi saben saham ing taun lumaku MoonLake MLTX|Crinetics Pharmaceuticals, Inc. (CRNX) - Kacepetan wutah bathi saben saham ing taun lumaku|NAMS - Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi saben saham ing taun lumaku|FOLD: Wutah bathi ing taun lumaku|ETNB - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Agios Pharmaceuticals, Inc.|Structure Therapeutics Inc (GPCR) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku MiMedx Group (MDXG)|Wutah bathi resik saben saham ing taun iki Rezolute Bio RZLT|Wutah bathi ing taun lumaku LXRX (Lexicon Pharmaceuticals)|Wutah bathi ing taun lumaku mbxbio.com MBX|ALT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Aardvark Therapeutics Inc. AARD|SGMT: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki BioAge Labs, Inc|BMEA (Biomea Fusion, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Quince QNCX|Wutah bathi saben saham ing taun lumaku Fractyl Health (GUTS)|vtvtherapeutics.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ATPC (Agape ATP)|PLUR: Wutah bathi saben saham ing taun iki|Synlogic Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki lipocine.com LPCN|matinasbiopharma.com (MTNB) - Wutah bathi saben saham ing taun lumaku|SPRB - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki GLTO|CTCX: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Lumos Pharma, Inc. (LUMO)|ONVO: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku RDUS (Radius Recycling)
